Financials
- Market Capitalization 20.38 M
- Employee 8
- Founded 1996
- CEO N/A
- Website www.neuphoriatx.com
- Headquarter Australia
- FIGI BBG01RFZ8658
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.42
Fiyat/satışlar oranı
207.27
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4564 | LGVN Longeveron Inc. - Class A Common stock | 6.56 USD | -2.38% | +700.00% | +823.94% | +1048.26% | 20.91 M USD | ||
| 4573 | DYAI Dyadic International, Inc. - Common Stock | 0.56 USD | -8.20% | -21.13% | -46.15% | -38.46% | 20.41 M USD | ||
| 4578 | AKTX Akari Therapeutics Plc - American Depositary Shares | 10.27 USD | -4.02% | +35.85% | +36.75% | +1233.77% | 20.00 M USD | ||
| 4584 | ENLV Enlivex Ltd. - Ordinary Shares | 1.24 USD | -8.15% | -16.22% | -42.06% | +19.23% | 19.62 M USD |